19 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRB | UK£1.44 | 5.5% | 165.7% | UK£108.7m | UK£1.53 | PE6.8x | E34.2% | n/a | Materials | ||
HUW | UK£2.23 | 0% | 60.4% | UK£159.1m | UK£2.39 | PE9x | E23.1% | 2.7% | Insurance | ||
VIC New | UK£1.00 | -5.1% | 20.9% | UK£324.6m | UK£1.21 | PE59x | E37.6% | 1.6% | Retail | ||
LSL | UK£2.86 | 1.4% | 2.1% | UK£293.1m | UK£3.94 | PE22.9x | E26.9% | 4.0% | Real Estate Management and Development | ||
AT. | UK£5.41 | 0.9% | -21.4% | UK£434.4m | UK£8.31 | PE17.7x | E19.8% | 0.2% | Capital Goods | ||
PAF | UK£0.36 | -13.1% | 115.0% | UK£735.6m | UK£0.45 | PE11.5x | E33.4% | 2.7% | Materials | ||
ECEL | UK£1.47 | 0.7% | 18.5% | UK£149.2m | UK£2.48 | PE11.9x | E22.3% | 3.9% | Capital Goods | ||
AZN | UK£118.02 | 6.1% | 21.4% | UK£183.0b | UK£140.87 | PE32.4x | E16.4% | 2.1% | Pharmaceuticals & Biotech | ||
RNO | UK£0.48 | -4.2% | 10.0% | UK£96.1m | UK£0.89 | PE6.6x | E23.0% | 1.0% | Capital Goods | ||
TRN | UK£3.58 | -0.2% | 11.0% | UK£1.6b | UK£4.60 | PE28.6x | E16.7% | n/a | Consumer Services | ||
JSG | UK£1.38 | -0.7% | -0.6% | UK£570.8m | UK£1.90 | PE18.4x | E20.8% | 2.3% | Commercial Services | ||
JD. | UK£0.87 | 3.3% | -19.5% | UK£4.5b | UK£1.25 | PE13.2x | E23.2% | 1.1% | Retail | ||
III | UK£40.18 | 1.3% | 68.3% | UK£38.8b | UK£40.87 | PE9.2x | E17.7% | 1.6% | Diversified Financials | ||
KETL | UK£0.51 | 1.0% | -24.7% | UK£117.7m | UK£0.88 | PE16.4x | E44.9% | 0% | Tech | ||
GMR | UK£0.39 | 0.3% | 7.7% | UK£115.0m | UK£0.54 | PE17.1x | E22.0% | n/a | Media | ||
COA | UK£0.91 | -1.6% | 29.1% | UK£1.4b | UK£1.23 | PE18x | E16.9% | 2.6% | Consumer Durables | ||
TBCG | UK£40.10 | 18.6% | 41.4% | UK£2.2b | UK£48.00 | PB1.5x | E15.5% | 4.9% | Banks | ||
OTB | UK£2.55 | 0.4% | 78.3% | UK£411.1m | UK£2.98 | PE20.4x | E20.7% | 1.2% | Consumer Services | ||
CLIG | UK£3.58 | 3.8% | -1.1% | UK£174.9m | n/a | PE12.7x | E25.4% | 9.0% | Diversified Financials |